PULMATRIX, INC. Depreciation and Amortization, Discontinued Operations
PULMATRIX, INC. (PULM) reported Depreciation and Amortization, Discontinued Operations of $19.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationAndAmortizationDiscontinuedOperations · last filed 2021-03-23
- PULMATRIX, INC. depreciation and amortization, discontinued operations for fiscal 2020 was $19.00K, a 46.15% increase from fiscal 2019.
- PULMATRIX, INC. depreciation and amortization, discontinued operations for fiscal 2019 was $13.00K, a 98.68% decline from fiscal 2018.
- PULMATRIX, INC. depreciation and amortization, discontinued operations for fiscal 2018 was $985.00K, a 1995.74% increase from fiscal 2017.
- PULMATRIX, INC. depreciation and amortization, discontinued operations for fiscal 2017 was $47.00K, a 74.46% decline from fiscal 2016.
| Period end | Depreciation and Amortization, Discontinued Operations 12 month |
|---|---|
| 2020-12-31 | $19.00K 10-K · filed 2021-03-23 |
| 2019-12-31 | $13.00K 10-K · filed 2021-03-23 |
| 2018-12-31 | $985.00K 10-K · filed 2020-03-26 |
| 2017-12-31 | $47.00K 10-K · filed 2019-02-19 |
| 2016-12-31 | $184.00K 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |